The University of Southampton
University of Southampton Institutional Repository

The role of intravascular factors in systemic sclerosis and the effect of various therapeutic agents

The role of intravascular factors in systemic sclerosis and the effect of various therapeutic agents
The role of intravascular factors in systemic sclerosis and the effect of various therapeutic agents

Systemic sclerosis is a disease characterised by reduced blood flow to the skin, the digits and to various organs in the body. The exact initiating factors remain unknown but it is now clear that damage to the vascular endothelium is of primary importance. This results in both morphological changes in blood vessels and functional changes in blood flow which then go on to produce the sclerosis which is the hallmark of the disease. Treatment with the vasodilator nifedipine significantly reduces the number and severity of Raynaud's episodes as well as helping to heal digital ulcers in these patients, although the drug has no demonstrable effect on digital blood flow. This suggests that the mode of action is mediated via a mechanism other than simple vasodilatation. A variety of intravascular factors, including red cell rheology, white cell activation, platelet activity and thrombolysis, have been implicated in this disease. This thesis examines the role of these factors in the pathogenesis of systemic sclerosis and whether they are amenable to treatment with calcium channel antagonists. The ability of red cells to deform is a critical determinant of the flow through the microvasculature. Using a filtration technique, it is clear that the deformability of red cells from patients with systemic sclerosis is diminished and that this can be significantly enhanced in vitro by calcium channel antagonists. It is likely that the reduced filterability is secondary to an increase in intracellular Ca2+, as red cells from patients with systemic sclerosis have increased influx of Ca2+ across their membranes which can be blocked ex vivo by nifedipine. This alteration in calcium flux is probably mediated via intracellular cAMP as forskolin, prostacyclin, and a phosphodiesterase inhibitor, all known modulators of cAMP activity, result in improved red cell filterability. Nifedipine does not however, affect red cell charge which is reduced in systemic sclerosis. In addition, nifedipine does not influence the production of hydrogen peroxide by polymorphonuclear leucocytes which is significantly increased in systemic sclerosis, as measured by whole blood and isolated polymorphonuclear leucocyte chemiluminescence. Calcium channel antagonists do, however, correct the abnormal activation of platelets and the disturbed thrombolysis demonstrated in patients with systemic sclerosis using the novel instrument, the haemostatometer. There is no doubt that the intravascular changes described above influence disease progression in patients with systemic sclerosis. Unfortunately it has not been possible to correlate these changes with disease activity but this reflects the lack of suitable criteria for quantifying `disease activity'.

University of Southampton
Rademaker, Marius
Rademaker, Marius

Rademaker, Marius (1991) The role of intravascular factors in systemic sclerosis and the effect of various therapeutic agents. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Systemic sclerosis is a disease characterised by reduced blood flow to the skin, the digits and to various organs in the body. The exact initiating factors remain unknown but it is now clear that damage to the vascular endothelium is of primary importance. This results in both morphological changes in blood vessels and functional changes in blood flow which then go on to produce the sclerosis which is the hallmark of the disease. Treatment with the vasodilator nifedipine significantly reduces the number and severity of Raynaud's episodes as well as helping to heal digital ulcers in these patients, although the drug has no demonstrable effect on digital blood flow. This suggests that the mode of action is mediated via a mechanism other than simple vasodilatation. A variety of intravascular factors, including red cell rheology, white cell activation, platelet activity and thrombolysis, have been implicated in this disease. This thesis examines the role of these factors in the pathogenesis of systemic sclerosis and whether they are amenable to treatment with calcium channel antagonists. The ability of red cells to deform is a critical determinant of the flow through the microvasculature. Using a filtration technique, it is clear that the deformability of red cells from patients with systemic sclerosis is diminished and that this can be significantly enhanced in vitro by calcium channel antagonists. It is likely that the reduced filterability is secondary to an increase in intracellular Ca2+, as red cells from patients with systemic sclerosis have increased influx of Ca2+ across their membranes which can be blocked ex vivo by nifedipine. This alteration in calcium flux is probably mediated via intracellular cAMP as forskolin, prostacyclin, and a phosphodiesterase inhibitor, all known modulators of cAMP activity, result in improved red cell filterability. Nifedipine does not however, affect red cell charge which is reduced in systemic sclerosis. In addition, nifedipine does not influence the production of hydrogen peroxide by polymorphonuclear leucocytes which is significantly increased in systemic sclerosis, as measured by whole blood and isolated polymorphonuclear leucocyte chemiluminescence. Calcium channel antagonists do, however, correct the abnormal activation of platelets and the disturbed thrombolysis demonstrated in patients with systemic sclerosis using the novel instrument, the haemostatometer. There is no doubt that the intravascular changes described above influence disease progression in patients with systemic sclerosis. Unfortunately it has not been possible to correlate these changes with disease activity but this reflects the lack of suitable criteria for quantifying `disease activity'.

This record has no associated files available for download.

More information

Published date: 1991

Identifiers

Local EPrints ID: 460651
URI: http://eprints.soton.ac.uk/id/eprint/460651
PURE UUID: a3952ea9-9247-45c7-a4be-cfd4cfb0ddf1

Catalogue record

Date deposited: 04 Jul 2022 18:26
Last modified: 04 Jul 2022 18:26

Export record

Contributors

Author: Marius Rademaker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×